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Abstract 
Study Objectives 
Growing evidence suggests that nightmares have considerable impact on waking behaviour, 
possibly by increasing post-sleep negative emotions. Dysphoric reactions to nightmares are one 
component of nightmare severity for which the neural correlates are unknown. Here, we 
investigate possible neural correlates of nightmare severity in a sample of frequent nightmare 
recallers.  
Methods 
Our principal measure of nightmare severity is nightmare distress as indexed by the Nightmare 
Distress Questionnaire (NDQ), and our secondary measures retrospective and prospective 
estimates of frequency of recalling dysphoric dreams (DD). We used high resolution 99m-Tc-ECD 
SPECT to assess regional cerebral blood flow (rCBF) while 18 frequent nightmare recallers 
viewed negative and neutral pictures from the International Affective Picture System. We 
correlated rCBF with NDQ scores and DD recall frequency estimates. 
Results 
Negative correlations were observed between NDQ scores and rCBF during negative picture-
viewing in bilateral insula and anterior cingulate, right medial frontal gyrus, bilateral superior 
temporal gyrus, right inferior frontal and precentral gyri, and bilateral putamen. Retrospective 
DD recall correlated with rCBF activity primarily in regions overlapping those related to NDQ 
scores. Prospective DD recall was only weakly related to rCBF. Results for the neutral condition 
overlapped partially with those for the negative condition. Particularly, NDQ and retrospective 
DD recall were related to rCBF in medial prefrontal and anterior cingulate gyri. 
Conclusions 
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Results point to a possible overlap in brain mechanisms involved in nightmare dysphoria (during 
sleep) and distress (during wakefulness) among frequent nightmare recallers. They provide 
partial support for a neurocognitive model of nightmares.  
Keywords  
Nightmares; Parasomnias; Brain Imaging; Distress; Psychopathology 
Brief Summary 
Current Knowledge/Study Rationale: There is growing evidence that nightmares can cause 
clinically significant distress and may be a risk factor for psychopathology and suicidal behavior. 
However, there is a paucity of research on the neural mechanisms of nightmares, especially of 
non-traumatic nightmares. We therefore studied nightmare recallers using SPECT imaging. 
Study Impact: This study is among the first to investigate the neural correlates of disturbed 
dreaming, and the first to use nightmare frequency and distress severity measures. Negative 
correlations between nightmare severity and anterior cingulate/medial prefrontal cortices activity 
partially support a neurocognitive model emphasizing prefrontal regulatory mechanisms, while 
secondary results suggest that reduced activity in a wide brain network may be involved in 
nightmare production. 
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Introduction 
Nightmares are a frequent comorbid symptom of various psychopathologies, including 
mood and anxiety disorders and, most notably, posttraumatic stress disorder (PTSD).1 Their 
prevalence in such conditions varies from, for example, 15% in anxiety disorders to 67% in 
PTSD. The presence of nightmares as a comorbid symptom tends to signal a greater severity of 
subjective distress in such pathologies. For example, in one large psychiatric sample (N=498), 
patients with frequent nightmares had more severe symptoms than did patients without 
nightmares.2 Even in the general population, nightmare occurrence and severity are associated 
with increased worry, depersonalization, hallucinatory experiences and paranoia.3  
Frequent nightmares observed in the absence of other clinically significant 
psychopathology are also termed ‘Nightmare Disorder’. A Nightmare Disorder diagnosis can be 
given when nightmares cause severe distress and impair daytime functioning.4 The prevalence of 
the disorder in adults is estimated to be between 1-8%. Typically, having nightmares at least 
weekly is considered clinically significant.4, 5  
 It remains unknown whether trait or state factors are more critical to the severity of 
nightmares,6, 7 and a better understanding of these factors’ contribution could greatly affect 
treatment strategies that aim to reduced waking distress. State factors (e.g., day-to-day changes 
in the presence of negative events that exceed emotion regulation capacity) are thought to be 
more closely associated with the frequency of disturbing dreams, while trait factors (e.g., a 
general disposition towards high negative affect and emotional reactivity) may be more likely to 
explain nightmare-induced distress, i.e., their intensity, impact on daytime functioning,8 and 
association with psychopathology.9, 10 The widely used concept of nightmare distress (NMD) is 
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one such trait factor that captures the severity of waking distress associated with nightmares and 
is related to psychopathology and motivation to seek treatment.11, 12    
 There is limited but consistent evidence that nightmares can impact daytime functioning. 
Among the rare studies that prospectively measure the impact of nightmares, Köthe & 
Pietrowsky13 compared self-reports of emotions following nights with and without nightmares 
and showed that participants felt more agitated, physically aroused, anxious and sad, less able to 
concentrate, less cheerful, and less self-confident among other differences on days after 
nightmares. Similarly, using a prospective design comparing nights with and without nightmares, 
Lancee & Schrijinemaekers14 found that nightmares produce daytime distress.  
 The potential for nightmares to induce lasting distress may be critical to the finding that 
nightmares are a risk factor for self-harm behaviors. In one study, prospectively measured 
nightmares were associated, in a unidirectional fashion, to a four-fold increase in self-harmful 
thoughts and behaviors; the relationship was mediated by post-sleep negative affect.15 
Accordingly, the personality trait of NMD can be seen as a general disposition to react to 
nightmares with these kinds of dysphoric responses, i.e., increased negative affect, suicidal 
ideation, self-harm and, possibly, maladaptive coping mechanisms. Closer study of the 
mechanisms and neural structures causing nightmares to negatively impact waking behavior 
could thus have substantial clinical utility, e.g., in suggesting types of maladaptive waking 
behaviors to target with therapy.  
 Our neurocognitive model7, 16 proposes that nightmares arise from disturbances in a fear 
extinction function of normal dreaming, a function that relies on a limbic-prefrontal emotion 
regulation network comprising primarily medial prefrontal cortex (mPFC), anterior cingulate 
cortex (ACC), hippocampus, and amygdala. These regions, which are active in REM sleep, have 
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well-documented emotion regulation functions, whether in rodents or in humans. According to 
the cross-state continuity assumption of the model, emotion regulation works in a similar fashion 
across states and participants suffering from nightmares are therefore likely to demonstrate 
corresponding alterations in daytime functioning.7, 16 
 By this account, nightmares may result from the disturbance of down-regulation, by 
mPFC and ACC, of fear processes governed by amygdala and hippocampus. In fact, limited 
evidence implicates ACC17 and mPFC18 in nightmare frequency, but these early reports do not 
directly consider nightmare-induced distress. Further, disturbances of this network could stem 
from adverse experiences occurring during a critical early developmental period, leading to 
premature development of emotion regulation abilities and remembrance of normally forgotten, 
distressful, memories.19 Accordingly, the experience of nightmares and a concomitant 
breakdown of the affect regulation function of dreaming may sensitize an individual to negative 
affect over and above the effects of diminished sleep quality or duration. This mechanism may 
help explain the negative impact of nightmares on waking emotions.13-15, 20 
 In sum, closer study of the waking state neural correlates of nightmare severity could lead 
to a better understanding of how nightmares impact emotions and behavior during wakefulness 
and, thus, how nightmares may influence various psychopathologies. Such work could contribute 
to more effective strategies for preventing nightmares, for coping with and treating nightmares, 
and for assessing putative neurobiological correlates of nightmares and their successful 
treatment. Thus, the goal of this study was to assess relationships between nightmare severity 
and brain activity during an induced dysphoric mood. Studying participants during waking state 
is coherent both with the definition of NMD as a daytime reaction to nightmares11, 12 and with the 
cross-state continuity assumption of the neurocognitive model of nightmares.7, 17, 18 
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Objectives and hypotheses 
 Our objective was to investigate if nightmare severity—and NMD in particular—is 
related to brain activity during wakefulness. Our primary endpoint was NMD, as measured by 
the Nightmare Distress Questionnaire (NDQ12), and our secondary measures retrospective and 
prospective recall of dysphoric dreams. Our secondary objective was to investigate whether 
dysphoric dream recall frequency measures are related to brain activity and if these relationships 
differ from those of nightmare distress. 
Given the scarcity of brain imaging studies of frequent nightmare recallers, we used the 
neurocognitive model of nightmares16 to formulate hypotheses. Specifically, we predicted that 
nightmare distress would be correlated with reduced activity measured via regional cerebral 
blood flow (rCBF) in bilateral prefrontal areas known to down-regulate fear processes governed 
by the amygdala, i.e. in the ACC and mPFC. We also expected NMD to be correlated with 
reduced activity in the hippocampus and increased activity in the amygdala. 
Material and methods Participants 
We recruited participants with frequent nightmare recall who were scanned using high 
resolution single photon emission computed tomography (SPECT) after receiving a radiotracer 
injection of Technecium-99m Ethyl Cysteinate Dimer (99mTc-ECD) during the viewing of 
negatively and neutrally valenced pictures. Participants were part of a larger project on the neural 
correlates of nightmares, preliminary findings for which have been presented at conferences 
and/or published as abstracts.18, 21 
Participants were recruited by advertisements on local university campuses, through our 
laboratory’s website and by word of mouth. They were aged 18-35 years and were fluent in 
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English or French. Each underwent a telephone screening interview and were included if they: 1) 
reported recalling at least two nightmares or bad dreams (dysphoric dreams without awakening) 
per week; 2) did not report presence of sleep disorders (e.g., isolated sleep paralysis, night 
terrors, narcolepsy); 3) reported at least average sleep quality and sleeping 6+ hours/night; 4) 
reported <10 consumption of alcohol/week, not using drugs except marijuana (1/month or less) 
and having a daily caffeine intake equivalent to 3 cups of coffee or less; 5) did not report recent 
(past six months) traumatic experiences; 6) did not report psychiatric or medical conditions 
susceptible to interact with dreaming or with participant’s ability to safely undergo the SPECT 
scan; and 7) took no medications other than oral contraceptives. For more details about 
screening, see ref22.  
Our initial sample included 23 frequent nightmares recallers (3M; 20F). Two participants 
reported a traumatic event on the PCL-5 and scored over the recommended cut-off point for 
PTSD, and two were mildly depressed (BDI-II>14); these were excluded from further analyses. 
Another participant had an abnormality on neuroimaging, so these SPECT images were excluded 
from analyses. The final sample included 18 right-handed frequent nightmare recallers (3M; 
15F).  
The study was approved by the Research Center’s ethics and scientific committees. 
Participants provided written informed consent after being given a complete description of the 
study protocol. They were compensated financially for time spent in the laboratory, 
parking/public transit, and meal expenses. 
Procedure 
 Participants completed questionnaires including, but not limited to, those listed in the 
Questionnaires section. Following their first laboratory visit, participants started home sleep-
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dream logs andhad brain scans scheduled one and two weeks later. When they returned to the 
laboratory (Figure 1), they were fitted with a forearm catheter and underwent the negative or the 
neutral picture-viewing condition. At picture #30 the radiotracer was injected. Picture-viewing 
was followed by a short humorous video to stabilize mood, then by the SPECT scan, and then 
participants could leave. They returned one week later for the second scan (same procedure: see 
Figure 1) preceded by the other picture-viewing condition. Half of the participants completed the 
neutral condition first, the other half completed the negative condition first. 
Questionnaires 
Participants completed the State-Trait Anxiety Inventory (STAI);23 the Beck Depression 
Inventory-II (BDI-II);24 the Nightmare Distress Questionnaire (NDQ);12 and the Posttraumatic 
Stress Disorder Checklist for DSM-5 (PCL-5).25 The BDI-II cut-off point of 14-19 for slight 
depression26 was applied in screening participants.  
Nightmare severity measures  
 Nightmare distress. The NDQ is a 13-item questionnaire (1-5 response scales, from 
‘never’ (1) to ‘always’ (5); total score of 13-65) assessing various forms of waking distress 
associated with nightmares. Initial validation studies11, 12 have found adequate internal 
consistency, with Cronbach’s alpha coefficients of .80-.90. Belicki11, 12 found both nightmare 
frequency and distress to be associated with interest in therapy for nightmares, with higher 
correlations for nightmare distress. While nightmare distress is related to nightmare frequency,11, 
27 it is primarily associated with psychopathology.10, 11 
Home sleep-dream log. Participants kept daily logs for 2 consecutive weeks beginning 
on the morning following the first lab visit. They used an interactive voicemail system28 for 
recording dream reports and rating  sleep features (quality, #hours, napping, #awakenings) and 
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dream content (recall clarity, positive and negative emotion, whether dream awakened them); 
most ratings used 1-9 Likert scales. Prospective dream recall (0/1) was scored as successful 
when recall clarity was ≥1/9; bad dream recall (0/1) when negative emotion was ≥5/9; a 
nightmare (0/1) when negative emotion was ≥5/9 and the dream caused an awakening. The 
dysphoric dream recall measure was the sum of the bad dream and nightmare recall measures. 
Results were computed to obtain weekly prospective frequencies for dreams, bad dreams, 
nightmares and dysphoric dreams (Table 1).  
Retrospective measures. Retrospective measures were derived from the initial telephone 
screening (conducted up to several weeks before the laboratory visit) and computed as weekly 
frequencies of recalling dreams, bad dreams, nightmares and dysphoric dreams (Table 1).  
Three measures were selected for assessment in relation to brain activity: Nightmare 
Distress Questionnaire (NDQ) total score and weekly dysphoric dream recall measured both 
prospectively (prosDD) and retrospectively (retroDD). Experimental condition 
International Affective Picture System (IAPS). During radio-tracer injection for the 
SPECT scan (see below), participants viewed negatively or neutrally valenced IAPS pictures.29 
Each participant viewed sets of both negative and neutral IAPS pictures (in counterbalanced 
order) in two separate brain imaging sessions scheduled one week apart. IAPS is a stimulus set 
that reliably elicits mood changes30 with each picture having been rated normatively for its 
emotional valence (negative vs. positive) and emotional arousal (intensity). Common themes for 
the selected negative pictures corresponded in a general way to themes typically reported to 
occur in nightmares, e.g., actual or threatened violence between humans, dangerous animals, and 
wounded or dead animals and humans. Common themes for the selected neutral pictures 
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included friendly interactions between humans, nonthreatening animals, and wilderness 
landscapes. 
Selected negative pictures had a normatively scored mean of 2.66 (SD=0.72) on the 9-
point valence scale (1=negative, 9=positive) and a mean of 5.67 (SD=0.74) on the 9-point 
arousal scale (1=calm, 9=excited). Selected neutral pictures had a normatively scored mean 
valence of 6.88 (SD=0.9) and a mean arousal of 4.0 (SD=0.79).  Pictures were ordered so that 
mean valence and arousal before and after picture #30 (timing of radiotracer injection) were 
similar. Using Inquisit software (version 4, Millisecond Software), participants were first shown 
10 practice pictures with normative mean valence of 6.92 (SD=1.11) and mean arousal of 4.57 
(SD=0.60) and then 48 negative or neutral pictures for 10 seconds each, with a 1-second inter-
picture interval. They were shown a humoristic 3-min video (Simon’s Cat, YouTube) to 
normalize mood after radiotracer uptake; as the majority of radiotracer uptake occurs in the 2 
minutes post-injection,31 this did not influence neuroimaging results. 
To evaluate stimulus efficacy, participants rated their emotional valence and arousal on 
the 1-9 scales using the Self-Assessment Manikin32 and rated 11 emotions on a modified 
Differential Emotions Scale33 using 1-5 scales (1=very little, 5=very strongly) four times: 1) 
before the practice, 2) after the practice, 3) after viewing 48 negative pictures, and 4) after 
viewing the humoristic video (See Figure 1).  Brain imaging 
Technecium-99m Ethyl Cysteinate Dimer (99mTc-ECD) SPECT image acquisition. 
SPECT image acquisition and analysis parameters were similar to those used by Baril el al.,34 
and used the same high-resolution (2.5mm full-width half-maximum (FWHM)) NeuroFOCUS 
scanner (NeuroPhysics, Shirley, MA, USA) although with a different radiotracer (99mTc-ECD in 
this study compared to 99mTc-HMPAO in Baril et al.). At IAPS picture #30 participants were 
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given a dose of 750 MBq of 99mTc-ECD followed by a 30cc saline flush. Ten minutes post-
injection, participants underwent a standard 30-minute image acquisition sequence. Cerebellum 
was excluded from analysis. Acquisitions all occurred between 9:30 and 16:45, according to 
participant preferences. 
 SPECT image analysis. Images were inspected visually for quality. We used SPM8 
(Statistical Parametric Mapping 8, Wellcome Trust Centre for Neuroimaging, Institute of 
Neurology, University College London, UK) with MatLab (ver8.6, The Mathworks, Natick, MA, 
USA) to preprocess images (coregistration and normalization to SPECT template, smoothing of 
14mm FWHM). rCBF values from each image were normalized for their individual global mean 
signal. Final voxel size was 2 X 2 X 2 mm. Statistical Analyses 
Demographics, questionnaires, screening interview, home sleep-dream log, picture-
viewing ratings. Distributions of these measures were examined for normality and descriptive 
statistics generated with SPSS 20 (IBM Inc., Armonk, USA).   
SPECT correlational analyses. Using a multiple regression design in SPM8 we 
separately correlated rCBF values sampled during viewing of negative and neutral pictures with 
NDQ scores, retroDD and prosDD using a statistical threshold of p<0.005 (uncorrected) and a 
cluster extent threshold of k>100, which corresponds to the minimal amount of contiguous 
voxels necessary for the cluster to be considered significant. Analyses were thus performed on 
every voxel of gray matter using a mask. The combination of liberal p-values and high cluster-
extent threshold is optimal for localizing seizure-onset zones in epileptic patients.35  
PickAtlas software (version 3.0.5)36 was used to identify significant regions from ICBM 
atlas; 37 and to create a gray matter mask. Significant clusters were displayed on the MRI 
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template included in the MRIcron program (http://people.cas.sc.edu/rorden/mricron/index.html). 
MRIcron was also used to generate figures.  
Results 
Demographics, questionnaires, screening interview, sleep-dream log, picture-
viewing ratings. Means and standard deviations for age, IAPS picture-viewing ratings, 
questionnaire scores and all retrospective and prospective dream recall frequencies are reported 
in Table 1. Pearson correlations revealed that NDQ scores were not associated with either STAI-
T or BDI-II scores (p>.20), and STAI-T and BDI-II scores were not intercorrelated (p>.20). 
Spearman correlations were computed between questionnaire variables and dream frequency 
measures, as the latter had skewed distributions (Table 2).  
SPECT correlational analyses: negative pictures.  There was a preponderance of 
negative correlations between rCBF and NDQ, retroDD and prosDD. First, there were negative 
correlations between rCBF and NDQ  in several brain regions (Table 3 and Figure 2), including 
bilateral cingulate gyrus, right medial frontal gyrus, bilateral superior temporal gyrus, right 
inferior frontal gyrus, left precentral gyrus, and bilateral anterior insula and putamen, but no 
positive correlations. 
Similarly, there were negative correlations between rCBF and retroDD in left anterior 
cingulate gyrus, bilateral medial frontal gyrus, left middle frontal gyrus, bilateral inferior frontal 
gyrus, and left putamen and insula (Table 3 and Figure 3), but no positive correlations. 
Finally, there were negative correlations between rCBF and prosDD in left middle frontal 
gyrus and left lateral orbitalfrontal gyrus (Table 3) and only minimal positive correlations in 
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right lingual gyrus (k=309, p<.001; X=12, Y=-54, Z=2, BA 18, t=5.58) and right middle 
temporal gyrus (k=165, p<.001; X=58, Y=8, Z=-20, BA 21, t=3.82).  
SPECT correlational analyses: neutral pictures. As for the negative pictures, there 
was a preponderance of negative correlations between rCBF and NDQ, retroDD and prosDD. 
First, there were negative correlations between rCBF and NDQ in several brain regions (see 
Table 4 and Figure 4), including bilateral anterior cingulate gyrus, left medial frontal gyrus, 
bilateral superior temporal gyrus, left middle temporal gyrus, postcentral gyrus, thalamus and 
putamen, and a positive correlation in left middle occipital gyrus (k=162, p<.001; X=-24, Y=-94, 
Z=6, BA 18, t=3.93).  
Additionally, there were negative correlations between rCBF and retroDD in right 
anterior cingulate gyrus, right medial frontal gyrus, left insula, and inferior, middle and superior 
frontal gyri (see Table 4). No positive correlations were observed. 
Finally, there was a negative correlation between rCBF and prosDD in left middle frontal 
gyrus (Table 4) and positive correlations in left anterior cingulate gyrus (k=121, p<.001; X=-2, 
Y=22, Z=-6, BA 24, t=4.07), right posterior cingulate gyrus (k=191; p<.001, X=10, Y=-46, Z=-
6, BA 29, t=3.85; p<.005, X=12, Y=-62, Z=12, BA 30, t=3.43 and p<.001, X=6, Y=-70, Z=8, 
BA 30, t=3.01) and right middle temporal gyrus (k=106, p<.005; X=50, Y=6, Z=-18, BA 21, 
t=3.60). 
Discussion 
Main SPECT findings. We aimed to evaluate whether nightmare severity, i.e., NDQ and 
retrospective and prospective dysphoric dream recall, were related to daytime rCBF activity 
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during negative and neutral picture viewing in our sample of 18 frequent nightmare recallers. 
Based on the neurocognitive model of nightmares,7, 16 we hypothesized reduced activity in a 
limbic-prefrontal emotion regulation network comprising primarily the mPFC, ACC, 
hippocampus, and amygdala to be related to nightmare severity. We found the relationships with 
mPFC and ACC, but not hippocampus or amygdala.  
Elevated NDQ scores were associated with reduced rCBF in widespread brain regions 
including frontal, cingulate, temporal and subcortical gray matter for both neutral and negative 
picture-viewing, and in insula and putamen uniquely for negative picture-viewing. Retrospective 
and prospective nightmare recall were associated with more localized rCBF alterations. 
Retrospective recall was linked to decreased rCBF primarily in frontal lobe extending to insula 
and cingulate for both conditions, as well as to putamen for negative pictures. Prospective recall 
was associated with reduced rCBF in small portions of frontal and temporal lobe. For neutral 
pictures, prosDD was positively associated with rCBF in posterior and anterior cingulate gyrus. 
 Thus, the three nightmare severity measures were associated with activity in largely 
different brain regions. However, two patterns of findings emerged that were generally similar 
for NDQ and retrospective recall. First, correlations between rCBF and these measures were 
predominantly negative in direction, indicating that greater levels of nightmare severity were 
associated with lower levels of brain activity in most brain regions.  
Second, both severity measures were associated with rCBF activity in one specific brain 
region, the medial prefrontal gyrus. Correlations were all negative, indicating that greater 
nightmare severity corresponded to lower waking-state mPFC activity. mPFC is implicated in 
regulating emotional activity; for example, veterans with PTSD who are presented with combat-
related pictures and sounds show reduced mPFC blood flow.38  
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These two general patterns of findings are consistent with the possibility that the 
underlying, cross-state neural deficit in nightmare production is a lack of regulatory control 
rather than an overactivation of regions responsible for emotional expression such as the 
amygdala or hippocampus. Together, the findings indicate that reductions in waking mPFC 
activity may well constitute our best available correlate of nightmare severity. 
Nightmare distress (NDQ). Brain activity was associated most prominently with the 
NDQ, a finding consistent both with the fact that nightmare distress is only modestly correlated 
with nightmare recall frequency and the fact that nightmare distress is more strongly correlated 
with psychopathology than is nightmare recall frequency.10, 11 The correlations we observed are 
thus consistent with the conclusion that nightmare distress is related to a more general problem 
of emotional adjustment.11  
Accordingly, the higher NDQ being associated with reduced rCBF in frontal areas, right 
mPFC and bilateral ACC in particular, is consistent with possible cross-state emotion regulation 
deficits among nightmare-prone individuals. Such deficits could lead directly to an increase in 
distress during both dreaming (nightmare dysphoria) and waking (nightmare distress). Our 
preliminary report showed ACC and mPFC hypoperfusion in nightmare recallers compared with 
controls,18 findings that are consistent with a previous report showing decreased ACC regional 
homogeneity in nightmare participants and correlation of this activity with some specific 
Nightmare Experience Questionnaire (NEQ) subscale scores.17 Although it is an indirect measure 
of brain connectivity, regional homogeneity gives information about the local synchronisation of 
brain activity. And while using different measures, our results and those of Shen et al.17 both 
implicate dorsal ACC, which is thought to be involved in the appraisal and expression of 
negative emotion—ventral ACC contributes to emotion by regulating limbic structures.39 Our 
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neurocognitive model does not deal directly with this distinction but it nevertheless proposes a 
specific role for ACC that is supported by the findings.  
Evidence implicating mPFC in nightmare etiology stems from neuropsychological results 
suggesting that nightmare recallers possess an inhibition deficit resulting in more perseveration 
errors on a verbal fluency task.40-42 This inhibition deficit may be linked to altered REM sleep 
mechanisms that facilitate the extinction of fear memories.7, 16, 19 It might also be linked to a 
more general difficulty in regulating stress, as suggested by nightmare recallers being willing to 
endure a stressful arithmetic task for a shorter time than controls.43  
It is noteworthy that our results were quite similar for both negative and neutral picture-
viewing conditions. It is possible that the negative pictures did not elicit strong emotional 
responses from participants (see the ‘unconfirmed predictions’ section). It is also possible that at 
least some of our results reflect cross-state emotions, including even those experienced during 
the resting state (see Shen et al. 17). Carr and Nielsen44 proposed that nightmare sufferers display 
enhanced emotional reactivity, even for positive stimuli.  
Nightmare distress is related to psychopathology measures, including depression and trait 
anxiety.10, 12 However, in our sample NDQ was not correlated with either BDI-II or STAI-T. It is 
unclear if this is due to insufficient statistical power: an expected correlation was observed, for 
example, between STAI-T and BDI-II. While nightmare distress is conceptually distinct from 
anxiety, the lack of correlations of the NDQ with STAI-T and BDI-II somewhat weakens the 
argument that nightmares are only a cross-state deficit in emotion regulation. Indeed, this 
argument rests on the premise that nightmare-related variables correlate with daytime pathology, 
including the dysfunctional regulation of anxiety. Reasons for this lack of replication remain 
unclear. 
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Additional findings. Most regions we found to be associated with nightmare distress are 
more active during REM sleep than during quiet wakefulness or NREM sleep. Indeed, superior 
temporal, anterior insular, medial frontal and anterior cingulate gyri are all active in REM sleep, 
as are basal ganglia (including putamen) and some thalamic nuclei.45 However, middle temporal 
gyrus is not selectively active during REM sleep, with the possible exception of REM sleep 
accompanied by lucid dreaming.46 Apart from such exceptions, the regions we found to be 
associated with NDQ in wakefulness could also play a role in normal REM dreaming.  
 The significance of reduced insula activity correlating with nightmare severity remains 
unclear. The insula has a well-documented role in emotion regulation and in functions such as 
emotional awareness, proprioception, pain perception, and autonomic regulation (for review 
see47); all of these functions could be relevant to nightmare formation. While there is still a 
scarcity of research on how insula activity changes during sleep, some studies suggest it remains 
as active during REM sleep as during wakefulness45 but serves functions often different from 
those of the waking state. Interestingly, insula alterations, whether anatomical48 or functional, are 
commonplace in PTSD, for example, during negative emotion processing,49 symptom 
provocation (reviewed in38), or flashbacks.50 
 Unconfirmed predictions. Some of our predictions were not confirmed. In particular, we 
did not observe expected relationships between NDQ and amygdala and hippocampal activities. 
The reasons for this are unclear. Shen et al.17 also found differences between nightmare 
participants and controls for ACC and a few other regions—but not for amygdala or 
hippocampus. One possible explanation for these findings is a lack of emotional engagement 
during the scan. Our picture stimuli may have been insufficiently arousing to engage these two 
key emotion regions because, for ethical reasons, we refrained from using the most extreme 
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IAPS pictures. Further, many participants may have become habituated by viewing such stimuli 
on TV, internet and other common media.  
Another possible explanation is that the pathological mechanism of nightmares is predominantly 
one of emotion regulation afforded by prefrontal regions such as mPFC51 but not a problem with 
either amygdala or hippocampus per se. As the mPFC is widely connected to nodes in the fear 
circuit, it is uniquely situated to gate fear expression, generalization and suppression.52 mPFC is 
widely thought to regulate amygdala activity, especially in the signalling of safety cues.51 In fact, 
mPFC coordinates theta oscillations with amygdala and hippocampus during fear learning and 
fear extinction and we have shown that frequent nightmare-recallers have abnormally high 
frontal theta power in REM sleep.22 Chronic hypoactivity of mPFC among nightmare recallers 
may thus reflect chronic fear overgeneralization or a fear-extinction deficit. To adequately test 
involvement of amygdala and hippocampus in nightmare pathology, future studies may require 
tasks with known effects on these regions, e.g., fear acquisition and extinction53 or cued fear 
conditioning.54  
It is possible that the predominance of females in our sample influenced the results. Thus, 
we included supplemental findings replicating the main analyses while a) including gender as a 
covariate (Tables S1 and S2) and b) removing male participants (Tables S3 and S4). Due to 
limited space, we did not include positive correlations. Overall, even controlling for gender, 
nightmare severity remains associated with mPFC and ACC activity. Some additional negative 
correlations emerged between severity and hippocampal/parahippocampal activity and, in one 
case, amygdala activity (neutral condition, female participants). This may reflect gender 
differences in emotion processing and regulation, including differences in response to our picture 
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stimuli. While it is more difficult to recruit male nightmare-prone participants, future work 
should investigate gender differences more thoroughly.   
The theoretical significance of our results is especially clear when considering the 
neurocognitive model of nightmares.7, 16 A number of studies are broadly consistent with the 
model, but very few have tested it directly. One study8 focused on validating the model’s 
constructs of affect load and affect distress. Another investigated neuropsychological functioning 
in nightmare recallers40 while only one (excluding preliminary findings from this project18) 
investigated the relationship between neural activity and nightmares in a nonpatient population 
using brain imaging.17 Our results partially validate this model by demonstrating that nightmare 
severity correlates with mPFC and ACC activity, while our secondary results suggest that a 
broader network is involved in nightmare production. The cross-state continuity assumption of 
the model is also compatible with these results. Other propositions of the model—for example, 
similarity of brain mechanisms for different kinds of dysphoric dreams, or specific processes of 
fear memory regulation during dreaming—could not be demonstrated directly in this study. In 
sum, while results are broadly consistent with the neurocognitive model, they introduce several 
new hypotheses for future testing. 
Limitations and future studies  
The present results are somewhat limited in that we assessed only nightmare severity in 
relation to rCBF rather than other sleep, dream and nightmare properties, e.g., nightmare 
chronicity, adversity/trauma history or coping strategies.13 However, our sample size constrained 
the number of variables that were statistically justified. Nonetheless, nightmare distress is 
arguably the most important clinical measure of nightmare severity as it is more highly 
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correlated with psychopathology and treatment-seeking than is nightmare frequency, while not 
being totally independent from the latter.10-12  
Only weak relationships were observed between our prospective measures and rCBF. 
This may be due to the importance of trait rather than state measures, or it may be that two weeks 
of dream diary was too short to adequately capture nightmare frequencies and produce sufficient 
variance.  
Our nightmare recall measures also differed somewhat from those used in previous 
studies. Retrospective and prospective nightmare recall measures are not highly correlated, and 
prospective measures provide higher estimates (e.g., Zadra & Donderi55). Why we found the 
opposite is unclear although it may be due to sample size, to nightmare participants being more 
severely affected or to methodological differences such as our use of a voice-mail system and 2-
week home logs rather than the manually reported 4-week logs.55 More critically, that our 
participants retrospectively estimated nightmares and dreams over a 1-week period—which is 
relatively insensitive to long-term recall fluctuations—whereas those in other studies used a 1–
year period55, may have produced higher estimates in our study. 
Future studies using brain imaging during REM sleep would permit even more direct 
tests of our hypotheses. Additionally, sampling the attributes of dreams (recall clarity, positive 
and negative emotion, etc.) and linking these with brain activity could provide valuable insights 
into potential dreaming dysfunction in nightmare pathology.  
While 99mTC-ECD SPECT captures brain activity in the few minutes following injection 
of a radiotracer, other methods (such as functional MRI) could monitor brain activity over time 
with better temporal and spatial resolution. This, in turn, could allow the implementation of more 
complex experimental procedures than mere picture-viewing.  
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Conclusion 
 This study examined the neural correlates of nightmare distress and, secondarily, of 
dysphoric dreaming frequency, using 99mTC-ECD SPECT imaging of a negative picture-viewing 
condition. Negative correlations were observed between nightmare distress and rCBF in mPFC, 
ACC, some subregions of parietal and temporal cortices, insula, thalamus and basal ganglia 
(putamen).  
  These results are consistent with a cross-state emotion regulation deficit; the regions 
associated with NDQ may be involved in distress both during and following nightmares. 
Consistent with this possibility is the fact that the regions associated with NDQ overlap regions 
active during REM sleep45 and some that are involved in emotion awareness and regulation 
during wakefulness.39  
  
 Future imaging studies could help clarify the emotion-processing functions of REM 
sleep, the consequences of disruptions of this function on daytime behavior, and ways to 
minimize the impact of nightmares as a clinical problem. 
Abbreviations 
NDQ = Nightmare Distress Questionnaires 
DD = Dysphoric dreams 
99m-Tc-ECD = Technecium-99m Ethyl Cysteinate Dimer 
SPECT = Single photon emission computerized tomography 
 rCBF = Regional cerebral blood flow 
PTSD = Posttraumatic stress disorder 
NMD = Nightmare distress 
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mPFC = Medial prefrontal cortex 
ACC = Anterior cingulate cortex 
STAI = State-Trait Anxiety Inventory 
BDI-II = Beck Depression Inventory-II 
PCL-5 = Posttraumatic Stress Disorder Checklist for DSM-5 
prosD = prospective dream recall per week 
prosBD = prospective bad dream recall per week 
prosNM = prospective nightmare recall per week 
prosDD = Prospective dysphoric dream recall per week 
retroD = retrospective dream recall per week 
retroBD = retrospective bad dream recall per week 
retroNM = retrospective nightmare recall per week 
retroDD = Retrospective dysphoric dream recall per week 
IAPS = International Affective Picture System 
SD = Standard Deviation 
FWHM = Full-width half-maximum 
MBq = Megabecquerel 
cc = Cubic centimeter 
SPM = Statistical Parametric Mapping 
BA = Broadmann area 
MNI = Montreal Neurological Institute 
NEQ = Nightmare Experience Questionnaire 
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Figure Captions 
Figure 1. Protocol for picture-viewing conditions and SPECT scan. 
Figure 2. Coronal and axial multislice view of hypoperfused regions associated with nightmare 
distress during negative picture-viewing. Color code; cyan – right medial frontal gyrus and left 
cingulate gyrus; green – right superior temporal gyrus; red – right putamen; fuschia – left 
superior temporal gyrus; yellow – right inferior frontal gyrus; white with red border – left 
putamen and insula; white with gray border – right insula; white with green border – left 
precentral gyrus and insula; white with blue border – right anterior cingulate gyrus and medial 
frontal gyrus. Significant regions were obtained with the following combination of statistical 
thresholds: peaks at p<0.005 within clusters >100. 
Figure 3. Coronal and axial multislice view of hypoperfused regions associated with 
retrospective dysphoric dream recall frequency during negative picture-viewing. Color code; 
cyan – middle frontal gyrus; green – left anterior cingulate and right frontal medial prefrontal 
gyri; red – left medial prefrontal gyrus; fuchsia – left middle inferior frontal gyrus; yellow – right 
inferior frontal gyrus; white with red border – left inferior temporal gyrus; white with gray 
border – left inferior frontal gyrus, putamen and insula. Significant regions were obtained with 
the following combination of statistical thresholds: peaks at p<0.005 within clusters >100. 
Figure 4. Coronal and axial multislice view of hypoperfused regions associated with nightmare 
distress during neutral picture-viewing. Color code; cyan – right superior temporal gyrus; green – 
left putamen; red – bilateral anterior cingulate gyrus; fuschia – left superior and middle temporal 
gyri; yellow – left superior temporal and postcentral gyri; white with red border – right thalamus; 
white with gray border – left anterior cingulate gyrus and medial frontal gyrus. Significant 
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regions were obtained with the following combination of statistical thresholds: peaks at p<0.005 
within clusters >100. 
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Tables 
Table 1. Participant characteristics 
Measures M SD 
Age (years) 24.94 3.86 
Sex (M:F) 3:15 
 
IAPS emotional valencec  2.61 1.24 
IAPS emotional arousalc 4.61 2.00 
IAPS emotional valenced 
IAPS emotional arousald 
 
STAI-Trait (raw score) 
5.62 
4.33 
 
33.56 
1.50 
1.68 
 
8.87 
STAI-State (raw score) 30.56 8.00 
BDI-II (raw score) 4.78 3.44 
NDQ (raw score)* 33.72 8.55 
 
Retrospective recalla   
Dreams (#/week) 6.33 3.00 
Bad dreams (#/week) 2.69 1.41 
Nightmares (#/week) 0.95 1.06 
Dysphoric dreams (#/week)* 3.65 1.59 
 
Prospective recallb   
Dreams (#/week) 2.25 1.62 
Bad dreams (#/week) 1.54 1.38 
Nightmares (#/week) 0.78 1.08 
Dysphoric dreams (#/week)* 2.33 1.65 
*Measures selected for SPECT correlational analyses; 
aRetrospective measures from screening interview; 
bProspective measures from sleep-dream log; cNegative 
condition; d Neutral condition; 
STAI-Trait: State-Trait Anxiety Inventory: Trait;  
STAI-State: State-Trait Anxiety Inventory: State; BDI-II: 
Beck Depression Inventory-II; NDQ: Nightmare Distress 
Questionnaire 
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Table 2. Spearman correlations for questionnaire responses and retrospective and prospective 
dream recall frequencies 
Variable NDQ BDI STAI retroD retroBD retroNM retroDD prosD prosBD prosNM 
NDQ -          
BDI-II .09 -         
STAI-T .14 .08 -        
retroD .28 -.02 -.05 -       
retroBD .32 -.003 .27 .28 -      
retroNM .09 .40 -.20 -.05 .07 -     
retroDD .40† .37 .11 .13 .71** .71** -    
prosD .03 .44† .37 .02 .05 .24 .29 -   
prosBD .34 -.32 -.19 .14 -.07 -.20 -.17 -.57* -  
prosNM -.01 .12 -.26 .11 -.02 .39 .18 -.44† .03 - 
prosDD .18 -.37 -.14 .22 -.06 .09 .04 -.70*** .69*** .62** 
† p < .10 ; *p < .05 ; **p < .01. ***p < .001 
NDQ: Nightmare Distress Questionnaire; BDI-II: Beck Depression Inventory; STAI-T: State-Trait Anxiety Inventory–Trait;   
retro: retrospective recall/week; pros: prospective recall/week: D: Dream; BD: Bad Dream; NM: Nightmare; DD: Dysphoric 
Dream 
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Table 3. Localization of hypoperfused regions associated with nightmare severity measures 
during negative picture-viewing  
 
Cluster size (k) 
 
Location 
 
P 
  Peak MNI coordinates 
Sid
e BA t-values x y z 
Nightmare distress 
667 Medial frontal gyrus <.001 R 24 5.37 0 2 46 
 Cingulate gyrus <.001 L 24 3.88 -4 16 32 
109 Superior temporal gyrus <.001 R 38 5.35 50 16 -20 
166 Putamen <.001 R - 4.32 20 4 6 
161 Superior temporal gyrus <.001 L 38 4.09 -42 10 -34 
100 Inferior frontal gyrus <.001 R 44 4.09 58 8 22 
335 Putamen <.001 L - 4.04 -16 8 6 
 Insula <.005 L 13 3.17 -32 14 -8 
142 Insula <.001 R 13 4.01 42 -22 4 
218 Precentral gyrus <.005 L 13 3.66 -50 -12 10 
 Insula <.005 L 13 3.63 -42 -8 10 
232 Anterior cingulate gyrus <.005 R 32 3.64 2 42 10 
  Medial frontal gyrus <.005 R 10 3.64 8 48 14 
Dysphoric dream frequency (retrospective estimate) 
867 Middle frontal gyrus <.001 L 10 7.18 -34 56 10 
 Middle frontal gyrus <.005 L 10 3.38 -42 44 22 
234 Anterior cingulate 
 
<.001 L 32 4.32 -6 26 -10 
  Medial frontal gyrus <.005 R 11 3.83 6 26 -12 
229 Medial frontal gyrus <.001 L 9 4.32 -12 38 28 
206 Middle frontal gyrus <.001 L 6 4.31 -54 2 44 
 Inferior frontal gyrus <.001 L 9 4.25 -52 10 34 
 Inferior frontal gyrus <.005 L 9 3.67 -62 10 24 
201 Inferior frontal gyrus <.001 R 10 4.12 52 48 0 
101 Inferior temporal gyrus <.005 L 20 3.91 -54 -8 -36 
181 Inferior frontal gyrus <.005 L a 3.37 -32 32 0 
 
 
Putamen <.005 L - 3.32 -20 8 6 
 Insula <.005 L a 3.30 -26 24 0 
 
  Dysphoric dream frequency (prospective estimate)  
 227 
Middle frontal gyrus <.001 L 11 4.63 -48 38 -16 
  Middle frontal gyrus <.001 L 11 3.84 -36 40 -20 
  Middle frontal gyrus =.001 L a 3.66 -36 54 -16 
 142 Middle frontal gyrus 
 
<.001 L 46 4.14 -56 28 32 
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180 Lat. orbitalfrontal 
 
<.001 L a 4.61 -12 10 -22 
MNI, Montreal Neurological Institute; BA, Brodmann area; L, left; R, right. Significant regions were obtained 
with the following combination of statistical thresholds: peaks at p<0.005 within clusters >100. aPickAtlas 
Software was unable to give BA equivalent. 
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Table 4. Localization of hypoperfused regions associated with nightmare severity measures 
during neutral picture-viewing  
 
 
Cluster size (k) 
 
 
Location 
 
 
P 
  Peak MNI coordinates 
Side BA t-values x y z 
Nightmare distress 
455 Superior temporal gyrus <.001 R 22 5.40 50 -8 2 
 Superior temporal gyrus <.001 R 22 4.21 56 -4 -4 
537 Putamen <.001 L - 4.93 -24 6 4 
954 Anterior cingulate gyrus <.001 R 32 4.87 6 28 26 
 Anterior cingulate gyrus <.005 L 32 3.66 -6 36 10 
 Anterior cingulate gyrus <.005 R 32 3.23 4 42 14 
162 Superior temporal gyrus <.001 L 38 4.70 -46 20 -30 
 Middle temporal gyrus <.005 L 21 3.15 -44 6 -34 
226 Superior temporal gyrus <.001 L 21 4.10 -60 -14 -2 
 Postcentral gyrus <.001 L 43 3.85 -52 -18 16 
101 Thalamus <.005 R - 3.64 2 -18 10 
147 Anterior cingulate gyrus <.005 L 32 3.34 -4 36 -10 
 Medial frontal gyrus <.005 L 11 3.13 -8 38 -18 
Dysphoric dream frequency (retrospective estimate) 
242 Superior frontal gyrus <.001 R 8 4.10 4 28 56 
324 Insula <.001 L 13 3.91 -40 -4 10 
 Insula <.001 L 13 3.69 -34 -14 8 
141 Anterior cingulate <.005 R 32 3.68 12 44 0 
 Anterior cingulate <.005 R 32 3.59 14 36 -4 
 Medial frontal gyrus <.005 R 10 3.26 16 48 10 
246 Middle frontal gyrus <.005 L 10 3.68 -38 54 12 
133 Inferior frontal gyrus <.005 L 47 3.31 -34 28 -2 
Dysphoric dream frequency (prospective estimate) 
102 Middle frontal gyrus <.001 R 9 4.13 -52 26 32 
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MNI, Montreal Neurological Institute; BA, Brodmann area; L, left; R, right. Significant regions were obtained with the 
following combination of statistical thresholds: peaks at p<0.005 within clusters >100. 
 
 
